1. Who’s Who on Glu? Meet the Team!

    Glu Staff Boston Team

      Every day, Glu gives you a question to ponder, opportunities to drive research, articles that teach or inspire, and a community of nearly 20,000 individuals who just “get it” — life with type 1 diabetes. But do you know who is behind the scenes, reading your comments, brainstorming new topics to explore, writing articles […]

    Read More
  1. Glucagon Survey

    What’s new in Glu Research? Together with Zealand Pharma, we’re studying emergency glucagon kits for the treatment of severe hypoglycemia. Your experience will help us understand their current usage and how to improve the emergency kits. Whether you’ve filled a prescription for glucagon or not, your insight is valuable! What challenges you may face—from out-of-pocket […]

    Read More
  2. Jerry the Bear Wins People’s Choice at Innovation Challenge

    Interactive stuffed animal helps young T1D patients develop good self-care habits Our recent Diabetes Innovation Challenge, the first-ever, open, worldwide challenge to identify and accelerate transformational advancements in diabetes research and care, awarded Sproutel the People’s Choice award. This is the third article in our three-part series of winner profiles.  Families, caregivers and clinicians guiding children […]

    Read More
  1. Parenting with T1D and not getting enough ZZZZZs? You’re not alone.

    Tired businesswoman in the office

      Getting quality sleep with T1D is a big issue. In fact, nighttime T1D care was identified in a T1D Exchange study as the ‘most challenging physical task’ in T1D management. Dr. Sarah Jaser, a pediatric psychologist at Vanderbilt University Medical Center who conducts behavioral research to promote the best outcomes in children with diabetes […]

    Read More
  2. T1D Management and Quality of Life Survey

    We all know managing diabetes has its challenges—and Glu has a new opportunity to get involved in research! In this month-long study, we aim to understand the connection between how you take insulin and how blood glucose levels influence your quality of life. Whether you use an insulin pump or daily injections, we’ll be gathering […]

    Read More
  3. Your Questions Answered: The MiniMed 670G System

    In September, the FDA approved a big leap forward in diabetes technology, the world’s first hybrid closed loop system. The MiniMed® 670G system is designed for people with type 1 diabetes who are 14 and older.  Having been diagnosed with type 1 in 1989, when blood glucose meters were bigger than the current larger iPhone, […]

    Read More
  4. T1D Exchange Joins Patient Groups’ Health Care Letter

      T1D Exchange is pleased to partner with 72 organizations that advocate on behalf of people with chronic, serious, and life-threatening diseases such as type 1 diabetes (T1D) to educate the incoming administration and Congress on the unique health insurance needs of our community. On December 14, 2016, we sent a letter to President-elect Trump […]

    Read More
  5. Promising Innovations in T1D Early Detection Emerge Victorious at Diabetes Innovation Challenge

    enable2

      Our recent Diabetes Innovation Challenge, the first-ever, open, worldwide challenge to identify and accelerate transformational advancements in diabetes research and care, awarded Enable Biosciences the top prize in late stage development. This is the second article in our three-part series of winner profiles.  An early diagnosis is one of the most important tools available […]

    Read More
  6. Implantable CGM Started as Caltech Graduate Project, Wins Top Prize at Diabetes Innovation Challenge

    t1dexchange-2016-0291

    As we’ve been reporting for several months, T1D Exchange recently teamed up with M2D2, a joint venture between the University of Massachusetts Lowell and UMass Medical School, for the Diabetes Innovation Challenge. The Challenge was the first-ever, open, worldwide challenge to identify and accelerate transformational advancements in diabetes research and care. There were two top winners, […]

    Read More